19095139

Source:http://linkedlifedata.com/resource/pubmed/id/19095139

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004153, umls-concept:C0008976, umls-concept:C0011860, umls-concept:C0037098, umls-concept:C0302891, umls-concept:C0360714, umls-concept:C0577631, umls-concept:C0723457, umls-concept:C1142985, umls-concept:C1280500, umls-concept:C1947925, umls-concept:C2603343, umls-concept:C2746065
pubmed:issue	25
pubmed:dateCreated	2008-12-19
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00047424
pubmed:abstractText	This secondary analysis from the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial examines the effects of lowering low-density lipoprotein cholesterol (LDL-C) with statins alone versus statins plus ezetimibe on common carotid artery intima-media thickness (CIMT) in patients with type 2 diabetes and no prior cardiovascular event.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1U01 HL67031-01A1, http://linkedlifedata.com/resource/pubmed/grant/U01 HL067031-01A1
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-10318659, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-10712410, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-11368702, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-12835406, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-1451262, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-14748765, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-15537681, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-17070147, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-17984165, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-18375999, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-18376000, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-18398080, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-18765433, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-19095140, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-4818200, http://linkedlifedata.com/resource/pubmed/commentcorrection/19095139-8319334
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Azetidines, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/ezetimibe
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1558-3597
pubmed:author	pubmed-author:FlegJerome LJL, pubmed-author:GallowayJames MJM, pubmed-author:HendersonJeffrey AJA, pubmed-author:HowardBarbara VBV, pubmed-author:HowardWm JamesWJ, pubmed-author:MeteMihriyeM, pubmed-author:RatnerRobert ERE, pubmed-author:RomanMary JMJ, pubmed-author:SilvermanAngelaA, pubmed-author:StylianouMarioM, pubmed-author:UmansJason GJG, pubmed-author:WeirMatthew RMR, pubmed-author:WilsonCharltonC
pubmed:issnType	Electronic
pubmed:day	16
pubmed:volume	52
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2198-205
pubmed:dateRevised	2010-9-22
pubmed:meshHeading	pubmed-meshheading:19095139-Anticholesteremic Agents, pubmed-meshheading:19095139-Azetidines, pubmed-meshheading:19095139-Biological Markers, pubmed-meshheading:19095139-Carotid Artery, Common, pubmed-meshheading:19095139-Carotid Artery Diseases, pubmed-meshheading:19095139-Cholesterol, LDL, pubmed-meshheading:19095139-Diabetes Complications, pubmed-meshheading:19095139-Diabetes Mellitus, Type 2, pubmed-meshheading:19095139-Disease Progression, pubmed-meshheading:19095139-Drug Therapy, Combination, pubmed-meshheading:19095139-Female, pubmed-meshheading:19095139-Humans, pubmed-meshheading:19095139-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:19095139-Linear Models, pubmed-meshheading:19095139-Male, pubmed-meshheading:19095139-Middle Aged, pubmed-meshheading:19095139-Prospective Studies, pubmed-meshheading:19095139-Severity of Illness Index, pubmed-meshheading:19095139-Tunica Intima, pubmed-meshheading:19095139-Tunica Media
pubmed:year	2008
pubmed:articleTitle	Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
pubmed:affiliation	National Heart, Lung, and Blood Institute, Bethesda, Maryland.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural